The most popular measure for conducting analyses in studies of adiposity is body mass index (BMI); however, BMI does not discriminate between muscle and adipose tissue and does not directly assess regional adiposity. In this article, we address the question of whether alternatives to BMI should be used in epidemiologic analyses of the consequences of obesity. In general, measures of fat distribution such as waist circumference and sagittal abdominal diameter are more highly correlated with cardiovascular disease risk factors and diabetes than BMI; however, differences are usually small. Precise measures of adiposity from methods such as dual-energy x-ray absorptiometry may provide more specific and larger associations with disease, but published studies show that this is not always true. Further, practical considerations such as cost and feasibility must influence the choice of measure in many studies of large populations. Measures of adiposity are highly correlated with each other, and the additional cost of a more precise measure may not be justified in many circumstances. Validated prediction equations that include multiple anthropometric measures, along with demographic variables, may offer a practical means of obtaining assessments of total adiposity in large populations, whereas waist circumference can provide a feasible assessment of abdominal adiposity. Finally, public health messages to the public must be simple to be effective. Therefore, investigators may need to consider the ease of translation of results to the public when choosing a measure.
Introduction
Epidemiologists interested in studying the health consequences of obesity are faced with the dilemma of how to measure excess adiposity. Measures commonly used in large studies include body mass index (BMI; kg/m 2 ), skinfolds, bioelectrical impedance analysis (BIA), waist circumference, hip circumference, waist-hip ratio (WHR), sagittal abdominal diameter and more recently, dual-energy x-ray absorptiometry (DEXA). Currently, BMI is the most frequently used metric, and BMI cutoff points for defining overweight and obesity have been established by the World Health Organization 1 and the United States National Institutes of Health. 2 Nevertheless, BMI is often criticized for its lack of ability to differentiate between fat and muscle mass or to assess fat distribution. Thus the question arises, should BMI or other alternative measures of adiposity be used in epidemiologic analyses of the consequences of obesity? Would alternative measures result in stronger associations with adverse health outcomes? Addressing these questions involves examination of several attributes of potential measures. First, it is useful to know how similar different alternatives are to each other. If different measures essentially rank patients in the same way, then they will give similar results in many study designs. Also, it is important for epidemiologists to be aware of the correlations of different measures of adiposity with potentially confounding or moderating variables, such as age, smoking, gender and race/ethnicity. Ultimately, candidate measures of body fatness need to be directly compared for their value as predictors of health outcomes. For optimal utility, a metric should offer a high degree of reliability and produce comparable results across population groups. In addition, issues of cost and feasibility are important in the planning and execution of studies. Finally, to influence the public in the direction of positive change, the measure should be easily translatable into a public health message. We address these issues below.
Alternative measures of adiposity
BMI is relatively easy to measure in large populations; however, several other measures (for example, waist circumference, WHR, skinfolds and BIA) are also feasible to assess in large populations and are often used in epidemiologic studies. Measures are generally collected with the aim of estimating either total adiposity (for example, BMI, BIA, waist circumference and skinfolds) or distribution of fat (for example, waist circumference, hip circumference, WHR, sagittal abdominal diameter and skinfolds). Central body fat distribution, commonly referred to as the 'apple' shape (in which abdominal fat predominates), is thought to pose greater health risks than the 'pear' shape (in which hip-area fat predominates). 3 Visceral or deep abdominal fat is thought to produce greater risk for health problems than subcutaneous fat. More difficult and expensive but more precise measures of total adiposity are DEXA, isotope dilution, airdisplacement plethysmography (Bod Pod) and underwater weighing. Computed tomography (CT) and magnetic resonance imaging (MRI) offer greater precision for analyses of fat distribution, but also at greater cost and lesser convenience. Choosing from among the available options requires balancing feasibility and economy on the one hand with the need for greater precision on the other.
Correlations among measures of adiposity
Correlations among various individual measures of adiposity have been shown in a number of studies. For instance, in the Atherosclerosis Risk in Communities (ARIC) study, BMI was very highly correlated with hip circumference and waist circumference, 0.90 and 0.88, respectively ( Table 1) . The correlation of BMI with WHR was 0.43; correlation with the subscapular skinfold was 0.75 and with the triceps skinfold was 0.62. Height was not correlated with BMI (r ¼ À0.05), which is appropriate, as BMI was designed to be uncorrelated with height. Anthropometric correlations with BMI were also found in the Johnston County Osteoarthritis Project, 4 which employed precise DEXA scanning (Table 1 ). This study found that BMI was correlated with fat mass at 0.90 and with percentage of body fat at 0.69. Thus, BMI is highly correlated with fat mass and with waist circumference, and moderately correlated with several other measures of adiposity, which raises the question of whether the measures could be used interchangeably in situations in which a high level of precision is not required.
Correlations with potential confounders
Age Total adiposity and fat distribution are independently related to age. Both the Coronary Artery Risk Development in Young Adults (CARDIA) 5 study in young adults and the ARIC study in older adults 6 have shown that, on average, BMI increases from young adulthood to old age. Central body fat distribution also increases with age. Changes in body weight and shape over 25 years of aging were examined by Stevens et al. 7 in the biracial Charleston Heart Study. For this analysis, African-American/black and white men and women were examined in 1963 and again in 1988. Over the 25-year interval, adults (37-46 years of age at baseline) gained 5.4 kg and waist circumference also increased. Regression analysis showed that, with no change in BMI, waist circumference increased in all four race-gender groups over this time frame: 2.8 cm in white women, 6.6 cm in black women, 6.3 cm in white men and 7.5 cm in black men.
Smoking
Smoking is another common, potentially confounding variable that affects total adiposity and body shape. It is well known that smokers weigh less than non-smokers and that weight gain is often a consequence of smoking cessation. Shimokata et al. 8 demonstrated the independent associations of smoking with BMI and fat distribution. They calculated the expected change in WHR for patients who started and stopped smoking given their age and actual change in weight. The actual WHR changes associated with both smoking initiation and cessation were significantly larger than expected given the changes in weight. It is now well established that smoking promotes the apple body shape.
Gender
There are also associations between total and regional adiposity with gender. Women have substantially more total adipose tissue than men, with 'normal' levels being 20-30% shown that visceral fat stores tend to be larger in Asians than in whites of similar BMI.
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Correlations with risk factors and disease outcomes
There is an enormous literature examining the impact of adiposity and regional distribution of adiposity on risk factors. Our purpose here is not to summarize this literature but to highlight a few key studies that focus on comparison of the utility of measures of total and regional adiposity. One informative study compared the correlations between BMI and waist circumference and several risk factors for cardiovascular disease (CVD) in 10 969 non-Hispanic blacks, Mexican Americans and non-Hispanic whites from the third National Health and Nutrition Examination Survey (NHANES III). 21 The authors found that waist circumference was more highly correlated than BMI with several CVD risk factors, including low-density lipoproteins (LDLs), systolic and diastolic blood pressure and glucose ( Table 2 ). The authors concluded that waist circumference was preferred as an indicator of CVD risk for all three racial/ethnic groups ( Table 2) . Festa et al. 22 examined the relationships of some less traditional risk factors, fibrinogen and C-reactive protein (CRP), to various measures of body fat and body fat distribution using data from 1559 white, African-American/ (Table 3 ). In men, waist circumference showed the highest correlation. Results using adiposity assessments that included BIA were not very different from the less expensive measures of BMI, waist circumference and WHR (Table 3) . Janssen et al. 23 addressed whether adding BMI to waist circumference in an assessment of obesity-related comorbidity improved the prediction of health risks over that obtained from a single measure. They used data from 14 924 NHANES III patients grouped into categories of BMI and waist circumference. The authors compared the odds ratios (ORs) for hypertension, dyslipidemia, and metabolic syndrome across BMI categories before and after adjustment for waist circumference. In general, compared with normal weight patients, overweight and obese patients were more likely to have hypertension, dyslipidemia and metabolic syndrome. After adjusting for waist circumference category (normal or high), the results were attenuated but still higher in overweight and obese patients. In contrast, when waist circumference and BMI were included in the same regression model as continuous variables, the authors found only waist circumference to be a significant predictor of CVD risk factors. The authors concluded that waist circumference better explains obesity-related health risk than does BMI, although the conversion of the continuous variables into categorical variables could obscure this result. Sagittal abdominal diameter is a less commonly used alternative measure of fat distribution. It is measured on a recumbent patient, as the distance between the top of an examination table and the topmost point of the abdomen. It is used as an indicator of the amount of visceral abdominal fat. 14, 24 In a large cohort study of Kaiser Permanente members (n ¼ 101 765), sagittal abdominal diameter predicted coronary heart disease (CHD) risk after controlling for BMI and across race and gender groups. 25 Ohrvall et al. 27 and at least one has found that it is poorly correlated with visceral adipose tissue in obese individuals. 28 Overall, these results indicate that measures of abdominal fat distribution, such as waist circumference and sagittal diameter, appear to be slightly more highly correlated with CVD risk factors than BMI. The differences in correlations are generally small but tend to persist in multiple populations and ethnic groups.
Adiposity assessed by DEXA compared with anthropometric methods DEXA provides a very precise measure of total adiposity and might therefore be expected to provide measures that are more strongly related to risk than other, less precise assessments of adiposity. Sierra-Johnson et al. 29 compared adiposity measured by DEXA with traditional anthropometric measures (BMI, waist circumference and WHR) for the prediction of insulin sensitivity. They conducted multiple intravenous glucose tolerance tests using white men and women. DEXA was used to measure adiposity in four body sections: the head, upper body, abdomen and lower body. The researchers found that in male patients, after controlling for age, all predictive information on insulin sensitivity was provided by waist circumference. The ability to predict insulin sensitivity did not improve after including any of the DEXA measurements. In women, after adjusting for age, BMI and WHR, the prediction of insulin sensitivity improved when information on fat levels in the head was added to the equation. Overall, DEXA measures approximately equaled, but did not add to, the information provided by simpler measures such as BMI and waist circumference. Similar results were found by Abbate et al. 4 , who compared the strength of the associations with radiographic knee osteoarthritis for adiposity measured by DEXA to that of other measures. The authors examined 779 women, 45 years and older, who were from the Johnston County Osteoarthritis Project. Adjusted ORs comparing the fourth with the Selection of obesity measures J Stevens et al first quartiles of the body composition measures showed that BMI had the strongest associations with knee osteoarthritis (OR ¼ 5.27, 95% CI: 3.05, 9.13). Analyses of adiposity measures from DEXA and waist circumference produced significant ORs that tended to be lower than for BMI. When BMI was included in the model, these measurements were no longer associated, whereas the significant effect of BMI remained. In addition, these authors showed that WHR was not associated with knee osteoarthritis with or without BMI included in the model. The authors concluded that precise measurements of body composition and fat may not offer advantages over simpler measures, such as BMI or weight, when assessing the risk of knee osteoarthritis.
These studies offer an interesting contrast with regard to the utility of very precisely measured adiposity. For knee osteoarthritis, it is likely that it is the physical strain put on joints by excess weight that leads to disease. Therefore, it might be expected that BMI would predict disease better than fatness or fat distribution. Alternatively, for insulin resistance, metabolic pathways associated with excess adiposity are thought to lead to abnormalities, rather than weight per se. Therefore, it is surprising that the study of insulin resistance by Sierra-Johnson et al. 29 did not find that precise measures of adiposity yielded a stronger association. More studies are needed to confirm this unexpected finding. Both of the studies cited here used cross-sectional data, with their attendant limitations; however, they make it apparent that a very precise measure of adiposity is not necessarily more highly correlated with measures of risk than less precise measures.
Correlations with disease incidence and mortality
Type 2 diabetes is a disease that has been shown repeatedly to be related to adiposity and to adipose tissue distribution, and these measures offer a potential tool for screening and predicting future risk. Stevens et al. 30 evaluated the ability of BMI, waist circumference, WHR and combinations of these measures of adiposity to identify individuals who will develop diabetes. Data were from more than 12 814 African-American/black and white men and women who were between the ages of 45 and 64 years and were free of diabetes at baseline. Among the four race-gender groups, the incidence of diabetes over 9 years of follow-up was higher in African-American/black women and men (17.9 and 16.8%, respectively) than in white women and men (8.3 and 12.4%, respectively). The diagnostic accuracy of the anthropometric measures was determined by calculating the area under receiver operating characteristic (ROC) curves, which plot sensitivity against (1Àspecificity). In all racegender groups, waist circumference tended to have the largest area under the ROC curve compared with other anthropometric measures, but differences were small ( Table 4 ). The authors concluded that sensitivity and specificity differed between ethnic and gender groups but that BMI, WHR and waist circumference were approximately equivalent in their ability to predict diabetes (Table 4) . A number of studies compared adiposity and body fat distribution with mortality. In one cohort study of men 60 years of age, adiposity was measured using BMI, waist circumference and total body potassium. 31 The authors found mortality was negatively associated with fat-free mass. Increased mortality rates were seen with increased body fat. In addition, waist circumference was not statistically associated with mortality. The BMI association was U-shaped, with the nadir near the center of the distribution. Allison et al. 32 hypothesized that the U shape that is observed in studies of BMI and mortality might be driven by the risk associated with lower lean body mass. They used pooled anthropometric data and a hypothetical model of mortality in which both decreasing lean mass and increasing adiposity were associated with mortality. The resulting BMI-mortality association was indeed U-shaped, and the authors concluded that body composition measures rather than BMI should be used in future studies of mortality. More work is needed to determine whether other measures of lean and fat tissue would provide more insight into the association between BMI and mortality.
Practical considerations in the choice of measures
Feasibility and cost always play a role in the selection of measures for epidemiologic analyses. Indeed, many investigators find it feasible to use only information from 36 As more validated prediction equations become available, they may provide useful tools for obtaining more precise measures of total adiposity in the field.
Implications for public health
Very precise measures of a well-defined exposure are generally going to be the most useful in a study to determine the etiology of disease. However, precision in measurement and definition are not necessarily the most useful elements when faced with educating the public about risk factors and promoting action to reduce risk. A very strong attribute of a good measure in a public health setting is simplicity.
Although there are few data on this issue, it seems likely that weight is a measure that is well understood by the public, albeit in pounds in the United States and in kilograms in most other parts of the world. BMI is well known in medical and scientific settings but is somewhat complicated to calculate. Waist circumference has been advocated as a practical, easily obtained and understood measure. However, it is not traditionally collected in most medical settings, and identification of the correct body site for measure of this circumference introduces difficulties.
Percentage of body fat is more difficult to obtain than weight, BMI or waist circumference. It is difficult for individuals to accurately assess in their own homes, which is a very important limitation in public health, as it precludes self-monitoring. Overall, weight, BMI and waist circumference are probably the most useful measures for public health messages and monitoring, and therefore many investigators will choose to use those measures in studies in which translation of results to public health applications is a priority.
Conclusion
The best measure of adiposity in research should be based on study purpose, the required precision, cost, feasibility, specified outcome parameters and the intended use of results.
Often, a more precise measure is better, but it may not be affordable or absolutely necessary to answer a given research question. More precise measures have advantages in determining disease etiology, but may be less advantageous for use in messages to promote public health.
